Medicare Enrolled

Dr. Tiffany Harkleroad, NP

Nurse Practitioner - Family · Waycross, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1706 ALICE ST, Waycross, GA 31501
9124904673
In practice since 2019 (6 years)
NPI: 1174172142 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harkleroad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harkleroad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harkleroad

Dr. Tiffany Harkleroad is a nurse practitioner - family in Waycross, GA, with 6 years of NPI registration. Based on federal Medicare data, Dr. Harkleroad performed 16 Medicare services across 16 unique beneficiaries.

Between the years covered by Open Payments, Dr. Harkleroad received a total of $11,882 from 69 pharmaceutical and/or device companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harkleroad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ 16 Medicare services $11,882 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16
Medicare services
Bottom 3% in GA for nurse practitioner - family
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
16
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 16 $50 $218
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,882
Total received (2021-2024)
Avg $2,970/year across 4 years
Top 1% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
413
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,025 (84.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,857 (15.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,687
2023
$4,665
2022
$2,793
2021
$738

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$412
PFIZER INC.
$358
Astellas Pharma US Inc
$355
AstraZeneca Pharmaceuticals LP
$272
Genentech, Inc.
$250
ABBVIE INC.
$250
Daiichi Sankyo Inc.
$209
GlaxoSmithKline, LLC.
$206
Novartis Pharmaceuticals Corporation
$199
Pharmacosmos Therapeutics Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$112
SEAGEN INC.
$95
Bayer Healthcare Pharmaceuticals Inc.
$92
Janssen Biotech, Inc.
$79
E.R. Squibb & Sons, L.L.C.
$65
Fennec Pharmaceuticals, Inc.
$62
Eisai Inc.
$56
TAIHO ONCOLOGY, INC.
$56
Incyte Corporation
$46
Sumitomo Pharma America, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$38
ADC Therapeutics America, Inc.
$37
EMD Serono, Inc.
$31
Alexion Pharmaceuticals, Inc.
$27
Novocure Inc.
$26
TerSera Therapeutics LLC
$25
Octapharma USA, Inc.
$23
Deciphera Pharmaceuticals Inc.
$20
Immunocore Limited
$19
Lilly USA, LLC
$18
Exelixis Inc.
$16
Celgene Corporation
$16
Genentech USA, Inc.
$16
Gilead Sciences, Inc.
$15
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2021-2024) ›
Pharmacosmos Therapeutics Inc.
$1,080
Merck Sharp & Dohme LLC
$896
PFIZER INC.
$764
Novartis Pharmaceuticals Corporation
$648
Seagen Inc.
$643
AstraZeneca Pharmaceuticals LP
$622
Astellas Pharma US Inc
$553
E.R. Squibb & Sons, L.L.C.
$447
Takeda Pharmaceuticals U.S.A., Inc.
$390
Daiichi Sankyo Inc.
$357
GlaxoSmithKline, LLC.
$324
Kite Pharma, Inc.
$294
ABBVIE INC.
$288
Janssen Biotech, Inc.
$280
Amgen Inc.
$259
Genentech, Inc.
$250
Incyte Corporation
$225
G1 Therapeutics, Inc.
$196
Paratek Pharmaceuticals, Inc.
$166
Lilly USA, LLC
$155
JAZZ PHARMACEUTICALS INC.
$153
Exelixis Inc.
$152
Celgene Corporation
$149
Adaptive Biotechnologies Corporation
$147
GENZYME CORPORATION
$140
Gilead Sciences, Inc.
$123
Genentech USA, Inc.
$123
AbbVie Inc.
$115
Octapharma USA, Inc.
$115
Alkermes, Inc.
$100
SEAGEN INC.
$95
Bayer Healthcare Pharmaceuticals Inc.
$92
Alexion Pharmaceuticals, Inc.
$88
SERVIER PHARMACEUTICALS LLC
$88
Regeneron Healthcare Solutions, Inc.
$84
Eisai Inc.
$80
TAIHO ONCOLOGY, INC.
$79
Sumitomo Pharma America, Inc.
$65
Pharmacyclics LLC, An AbbVie Company
$64
EISAI INC.
$64
MorphoSys, US Inc.
$64
Myovant Sciences Inc.
$62
Fennec Pharmaceuticals, Inc.
$62
PharmaEssentia USA Corporation
$59
ADC Therapeutics America, Inc.
$51
Mirati Therapeutics, Inc.
$46
Karyopharm Therapeutics Inc.
$45
EUSA Pharma (US) LLC
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Rigel Pharmaceuticals, Inc.
$36
ARRAY BIOPHARMA INC
$36
Deciphera Pharmaceuticals Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$34
Taiho Oncology, Inc.
$31
EMD Serono, Inc.
$31
Novocure Inc.
$26
Coherus Biosciences Inc.
$26
TerSera Therapeutics LLC
$25
Puma Biotechnology, Inc.
$25
Foundation Medicine, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
Immunocore Limited
$19
Myriad Genetic Laboratories, Inc.
$17
Merck Sharp & Dohme Corporation
$15
Dova Pharmaceuticals
$15
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Servier Pharmaceuticals LLC
$12
Sun Pharmaceutical Industries Inc.
$12
Sobi, Inc
$12
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
Alecensa · BESREMI · BOSULIF · BRAFTOVI · Blincyto · CABOMETYX · CALQUENCE · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · Enhertu · FEMARA · FRUZAQLA · Fabhalta · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kerendia · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYBALVI · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NUZYRA · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Optune Lua (NovoTTF-200T) · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VRAYLAR · Venclexta · Veozah · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in GA.

Looking for a nurse practitioner - family in Waycross?
Compare family nurse practitioners in the Waycross area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
77
Per 100K population
214.1
County median income
$44,833
Nearest hospital
Memorial Satilla Health
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Harkleroad is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 1% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Harkleroad experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Harkleroad performed 16 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harkleroad receive payments from pharmaceutical companies?
Yes. Dr. Harkleroad received a total of $11,882 from 69 companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harkleroad's costs compare to other family nurse practitioners in Waycross?
Dr. Harkleroad's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harkleroad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Waycross
Browse family nurse practitioners in Waycross ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in GA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in GA
Which GA family nurse practitioners receive the most from drug and device companies.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →